FDA PMA FDA Class 3 Approved 🇺🇸 United States

System, Colorectal Neoplasia, Dna Methylation And Hemoglobin Detection

PMA: P230043 · Supplement: S007 · Decision Jun 2, 2026
Classifications
1
FEI Numbers
0
Registration Numbers
0

Basic Information

Device Name
System, Colorectal Neoplasia, Dna Methylation And Hemoglobin Detection
Trade Name
Cologuard Plus™
PMA Number
P230043
Supplement Number
S007
Device Class
FDA Class 3
Product Code
PHP
Generic Name
System, colorectal neoplasia, DNA methylation and hemoglobin detection
Medical Specialty
Unknown
Advisory Committee
Pathology
Decision
Approved
Decision Code
APPR
Decision Date
June 2, 2026
Date Received
March 6, 2026
Supplement Type
Real-Time Process
Supplement Reason
Change Design/Components/Specifications/Material
Expedited Review
N

Advisory Committee Statement

Approval to use a new Class I instrument, referred to as the Capture Aspiration Module (CAM), in the laboratory workflow of the Cologuard Plus test.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
PHP System, Colorectal Neoplasia, Dna Methylation And Hemoglobin Detection